|Articles|May 15, 2015
FDA Comments on Continuous Manufacturing
Advertisement
Christine Moore, acting director in the Office of Process and Facilities at at FDA's Center for Drug Evaluation and Research, spoke with Pharmaceutical Technology at Interphex 2015 about advances in continuous manufacturing, regulatory concerns, and next steps.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Renewing Prosaic Generics for Cancer Treatment
2
Viral Safety 2.0: Plant-Ready Actions for ICH Q5A(R2) Compliance
3
Leveraging an Innovative Mid-Scale Manufacturing Solution to Meet Diverse Needs
4
Faster Doesn’t Mean Easier: Development Impacts of a New Biosimilar Regulatory Landscape
5
